Literature DB >> 19752716

Crack cocaine use increases the incidence of AIDS-defining events in French Guiana.

Mathieu Nacher1, Antoine Adenis, Matthieu Hanf, Leila Adriouch, Vincent Vantilcke, Myriam El Guedj, Tania Vaz, Julie Dufour, Pierre Couppié.   

Abstract

We conducted a retrospective cohort study to determine the influence of crack cocaine use on the outcomes of HIV infection. The use of crack cocaine was associated with an increased incidence of AIDS: 27.8 per 100 person-years versus 6.6 per 100 person-years for nonusers, adjusted hazard ratio = 3.8 (1.9-7.5), P < 0.001. More specifically, crack users had a greater incidence of disseminated histoplasmosis, pneumocystosis, pulmonary tuberculosis, bacterial pneumonia, oesophageal candidiasis, cerebral toxoplasmosis, salmonellosis, and genital herpes. The care of HIV-infected crack users is particularly challenging and requires additional efforts to reduce the high morbidity of these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752716     DOI: 10.1097/QAD.0b013e32833147c2

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

1.  Crack cocaine-induced supraglottitis.

Authors:  Claudia Zacharias; Ken F Linnau; Justin S Golub; Tanya K Meyer; Avram S Hecht; Lorenzo Mannelli
Journal:  Emerg Radiol       Date:  2011-05-26

2.  Community-acquired lower respiratory tract infections in HIV-infected patients on antiretroviral therapy: predictors in a contemporary cohort study.

Authors:  Cristiane C Lamas; Lara E Coelho; Beatriz J Grinsztejn; Valdilea G Veloso
Journal:  Infection       Date:  2017-06-28       Impact factor: 3.553

3.  Correlates of antiretroviral utilization among hospitalized HIV-infected crack cocaine users.

Authors:  Rupali Kotwal Doshi; Nicholas S Vogenthaler; Sarah Lewis; Allan Rodriguez; Lisa Metsch; Carlos del Rio
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-02       Impact factor: 2.205

4.  Cocaine-using substance abuse treatment patients with and without HIV respond well to contingency management treatment.

Authors:  Ashley E Burch; Carla J Rash; Nancy M Petry
Journal:  J Subst Abuse Treat       Date:  2017-03-09

Review 5.  Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.

Authors:  Gregory M Lucas
Journal:  Life Sci       Date:  2010-10-01       Impact factor: 5.037

Review 6.  Associations between use of crack cocaine and HIV-1 disease progression: research findings and implications for mother-to-infant transmission.

Authors:  Judith A Cook
Journal:  Life Sci       Date:  2011-01-08       Impact factor: 5.037

Review 7.  Epigenetics, drugs of abuse, and the retroviral promoter.

Authors:  Jasmine Shirazi; Sonia Shah; Divya Sagar; Michael R Nonnemacher; Brian Wigdahl; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2013-11-12       Impact factor: 4.147

Review 8.  Stimulants and the lung : review of literature.

Authors:  Will Tseng; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

9.  Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohort.

Authors:  Nirzari Parikh; Will Dampier; Rui Feng; Shendra R Passic; Wen Zhong; Brian Frantz; Brandon Blakey; Benjamas Aiamkitsumrit; Vanessa Pirrone; Michael R Nonnemacher; Jeffrey M Jacobson; Brian Wigdahl
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

10.  Histoplasma capsulatum in Cayenne, French Guiana.

Authors:  Olivier Moquet; Denis Blanchet; Stéphane Simon; Vincent Veron; Myriam Michel; Christine Aznar
Journal:  Mycopathologia       Date:  2012-05-08       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.